Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver–Russell Syndrome and Focus on the IGF1R Gene
The Journal of Clinical Endocrinology & Metabolism · 17.03.2025 · 110 (4) · e932-e944
DOI: 10.1210/clinem/dgae730 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 16.10.2024. Verfasst von Alessandro Vimercati und 23 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy. Hauptthemen laut MEDLINE: Silver-Russell Syndrome, Receptor, IGF Type 1, Mutation, Receptors, Somatomedin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BIBLIOSAN.
Abstract (Originalsprache)
Context
Silver–Russell Syndrome (SRS) is a growth retardation disorder characterized by pre- and postnatal growth failure, relative macrocephaly at birth, prominent forehead, body asymmetry, and feeding difficulties. The main molecular mechanisms are imprinting alterations at multiple loci, though a small number of pathogenic variants have been reported in the SRS genes IGF2-PLAG1-HMGA2 and CDKN1C. However, around 40% of clinically suspected SRS cases do not achieve a molecular diagnosis, highlighting the necessity to uncover the underlying mechanism in unsolved cases.
Objective
Evaluate the frequency of genetic variants in undiagnosed SRS patients [Netchine–Harbison Clinical Scoring System (NH-CSS) ≥ 4], and investigate whether (epi)genetic patients may be distinguished from genetic patients.
Methods
One hundred thirty-two clinically SRS patients without (epi)genetic deregulations were investigated by whole-exome (n = 15) and targeted (n = 117) Sequencing. Clinical data from our cohort and from an extensive revision of the literature were compared.
Results
Pathogenic variants were identified in 9.1% of this cohort: 3% in IGF2, PLAG1, and HMGA2 genes and 3% in the IGF1R gene, associated with IGF-1 resistance (IGF1RES), an SRS differential diagnosis. Overall, IGF2-PLAG1-HMGA2 and IGF1R account for 3.6% of SRS with NH-CSS score ≥ 4. A clinical cross-comparison of (epi)genetic vs genetic SRS underlined (epi)genotype-phenotype correlation highlighted the prevalence of body asymmetry and relative macrocephaly in mosaic (epi)genetic SRS and recurrence of genetic familial cases. Furthermore, overlapping features were evidenced in (epi)genetic SRS and IGF1RES patients.
Conclusion
Our study explores the frequency of genetic SRS, underscores body asymmetry as a distinctive phenotype in (epi)genetic SRS and suggests IGF1R sequencing in a SRS diagnostic flowchart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
- Bioinformatics and Statistical Genomic Unit, IRCCS Istituto Auxologico Italiano, 20145 Milan, Italy.
- Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.
- Medical Genetics Unit, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.
- Pediatric Unit, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, 37129 Verona, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro," University of Palermo, 90127 Palermo, Italy.
ORCID-Profile: Flavia Napoli, Mohamad Maghnie, Silvia Russo
Förderung
- BIBLIOSAN
Zitieren
APA
Vimercati, A., Tannorella, P., Guzzetti, S., Calzari, L., Gentilini, D., Manfredini, E., Gori, G., Gaudino, R., Antona, V., Piccione, M., Daolio, C., Auricchio, R., Sirchia, F., Minelli, A., Rossi, E., Bellini, M., Biasucci, G., Raucci, A. R., Pozzobon, G., …, & Russo, S. (2025). Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver–Russell Syndrome and Focus on the IGF1R Gene. The Journal of Clinical Endocrinology & Metabolism, 110(4), e932-e944. https://doi.org/10.1210/clinem/dgae730
Vancouver
Vimercati A, Tannorella P, Guzzetti S, Calzari L, Gentilini D, Manfredini E, et al. Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver–Russell Syndrome and Focus on the IGF1R Gene. The Journal of Clinical Endocrinology & Metabolism. 2025;110(4):e932-e944. doi:10.1210/clinem/dgae730
BibTeX
@article{Vimercati2025,
author = {Vimercati, Alessandro and Tannorella, Pierpaola and Guzzetti, Sara and Calzari, Luciano and Gentilini, Davide and Manfredini, Emanuela and Gori, Giulia and Gaudino, Rossella and Antona, Vincenzo and Piccione, Maria and Daolio, Cecilia and Auricchio, Renata and Sirchia, Fabio and Minelli, Antonella and Rossi, Elena and Bellini, Melissa and Biasucci, Giacomo and Raucci, Annalisa Russo and Pozzobon, Gabriella and Patti, Giuseppa and Napoli, Flavia and Larizza, Lidia and Maghnie, Mohamad and Russo, Silvia},
title = {Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver–Russell Syndrome and Focus on the IGF1R Gene},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {4},
pages = {e932--e944},
doi = {10.1210/clinem/dgae730}
}
EUVIMED